Maryland, US-based healthcare firm WellDoc bagged $20 million from Windham Venture Partners and Merck Global Health Innovation Fund to market BlueStar, the first mobile therapy prescription for diabetes.
Medical
Integra picks up DuraSeal product line from Ireland's Covidien
New Jersey, US-based medical device company Integra LifeSciences Holdings Corp completed the acquisition of dural repair product lines from Dublin, Ireland-based manufacturer Covidien for an undisclosed sum, to add to its neurosurgery product portfolio.
American biotech startup QuanDx bags $950K in funding
Menlo Park, California-based biotech startup QuanDx bagged $950,000 in a recent financing round from undisclosed backers to continue developing molecular diagnostic equipment for medical laboratories.
Does taking more medicines make you sicker?
Patients with a single illness who take many drugs have an increased risk of being admitted to hospital, but for patients with multiple conditions, taking many medicines is now associated with a near-normal risk of admission.
US-based health consultation app First Opinion raises $1.2M in funding
US-based mobile health consultation app First Opinion raised $1.2M in funding from Greylock, Yuri Milner, Felicis Ventures, and 500 Startups to expland its consultants and workforce.
Latest News
British biotechnology startup QuantuMDx turned to crowdfunding platform Indiegogo to raise funds for the development and commercialization of a hand-held device that can diagnose malaria rapidly.
Gemany-based eHealth solutions provider CompuGroup Medical AG said it has inked an agreement to acquire France-based software maker Imagine Editions and Imagine Assistance for an undisclosed amount.
UK's Montagu Private Equity and Rexam have reportedly entered the advance stage of talks on the sale of the latter's healthcare packaging business. Rexam is selling its healthcare division in a deal that could value the asset at about £500 million.
Healogics Inc.,owned by private equity firm Metalmark Capital, is reportedly considering a sale that could value the wound care services provider at $1 billion. Goldman Sachs Group has been tapped to find a buyer.
Pharma giants Novartis International AG and Merck & Co. Inc. are reportedly negotiating an asset trade of about $5 billion each. Novartis wants to exchange its animal health and human vaccines businesses for Merck's over-the-counter health products unit.
McKesson Corporation has sweeten its offer for German counterpart Celesio AG in a bid to win over hedge fund Elliott Management Corporation. McKesson has lifted its bid from €23 per Celesio share to €23.50 apiece.
India-based global marketing solutions company Indegene acquired Atlanta, US-based outcomes research firm Total Therapeutic Management (TTM) for an undisclosed sum to expand its presence in the US.
California, US-based innovative diabetes management startup Glooko landed $7 million in a funding round led by Samsung Venture Investment Company and Lifeforce Ventures to expand its predictive diabetes care service.
AstraZeneca's MedImmune unit has partnered with Immunocore, a private British biotechnology company, to develop a cancer drug that would tap on the body's immune system, Reuters reported.
